Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [41] Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1
    Miyauchi, Tomoo
    Kanda, Tatsuo
    Imazeki, Fumio
    Mikata, Rintaro
    Tawada, Akinobu
    Arai, Makoto
    Fujiwara, Keiichi
    Nakamoto, Shingo
    Wu, Shuang
    Tanaka, Takeshi
    Miyamura, Tatsuo
    Kimura, Michio
    Hirai, Yasuo
    Takashi, Motohide
    Mikami, Shigeru
    Sugiura, Nobuyuki
    Natsuki, Yutaka
    Azemoto, Ryosaku
    Suzuki, Noriaki
    Yokosuka, Osamu
    HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 144 - 152
  • [42] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Toshifumi Tada
    Takashi Kumada
    Hiroaki Okushin
    Joji Tani
    Koichi Takaguchi
    Akemi Tsutsui
    Hidenori Toyoda
    Satoshi Yasuda
    Kazufumi Dohmen
    Atsushi Hiraoka
    Kojiro Michitaka
    Kazuhiro Nouso
    Kazuya Kariyama
    Soo Ryang Kim
    Soo Ki Kim
    Shinichi Fujioka
    Shigeru Mikami
    Yuto Watanabe
    Tsutomu Tamai
    Masanori Atsukawa
    Norio Itokawa
    Hironori Tanaka
    Kunihiko Tsuji
    Toru Ishikawa
    Michitaka Imai
    Ei Itobayashi
    Hiroshi Shibata
    Noritomo Shimada
    Infectious Diseases and Therapy, 2021, 10 : 269 - 280
  • [43] The efficacy of sofosbuvir and ribavirin in patients with chronic hepatitis C virus genotype 2 infection
    Kwan, Byung Soo
    Shim, Sang Goon
    Yu, Kil Jong
    Cho, Dae Hyeon
    Oh, Ji Eun
    Jeong, Chang Wook
    Kim, Kwang Min
    Lee, Hyoun Soo
    Lee, Jung Won
    Lee, Dong Kyu
    Choi, Ik Sung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 439 - 439
  • [44] Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients
    Brown, Kristen
    LaBrie, Martin
    Coffin, Carla S.
    CURRENT HIV/AIDS REPORTS, 2013, 10 (04) : 420 - 427
  • [45] Treatment of Genotype 2 and Genotype 3 Hepatitis C Virus (HCV) Infection in Human Immunodeficiency Virus Positive Patients
    Kristen Brown
    Martin LaBrie
    Carla S. Coffin
    Current HIV/AIDS Reports, 2013, 10 : 420 - 427
  • [46] Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection
    Hayashi, Takehiro
    Tamori, Akihiro
    Nishikawa, Manabu
    Morikawa, Hiroyasu
    Enomoto, Masaru
    Sakaguchi, Hiroki
    Habu, Daiki
    Kawada, Norifumi
    Kubo, Shoji
    Nishiguchi, Shuhei
    Shiomi, Susumu
    LIVER INTERNATIONAL, 2009, 29 (01) : 126 - 132
  • [47] Clinical and virological predictors of sustained response with an interferon-based simeprevir regimen for patients with chronic genotype 1 hepatitis C virus infection
    D'Offizi, Gianpiero
    Camma, Calogero
    Taibi, Chiara
    Schlag, Michael
    Weber, Karin
    Palma, Maria
    De Masi, Ralph
    Janssen, Katrien
    Witek, James
    Lionetti, Raffaella
    NEW MICROBIOLOGICA, 2017, 40 (01) : 19 - 26
  • [48] GB virus C hepatitis G virus infection in patients with chronic hepatitis C virus infection
    Suzuki, K
    Mizokami, M
    Saleh, MG
    Kondo, Y
    Hattori, K
    Kun, C
    Tibbs, CJ
    Williams, R
    HEPATOLOGY RESEARCH, 1998, 11 (02) : 95 - 102
  • [49] Genotype impact on long-term virological outcome of chronic hepatitis B virus infection
    Malmstrom, Sebastian
    Eilard, Anders
    Larsson, Simon B.
    Hannoun, Charles
    Norkrans, Gunnar
    Lindh, Magnus
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (04) : 321 - 326
  • [50] Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection
    Robinson, Mark W.
    Aranday-Cortes, Elihu
    Gatherer, Derek
    Swann, Rachael
    Liefhebber, Jolanda M. P.
    Filipe, Ana Da Silva
    Sigruener, Alex
    Barclay, Stephen T.
    Mills, Peter R.
    Patel, Arvind H.
    McLauchlan, John
    LIVER INTERNATIONAL, 2015, 35 (10) : 2256 - 2264